• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分光光度法和荧光法在生物素酶缺乏症评估中的比较

Comparison of Spectrophotometric and Fluorimetric Methods in Evaluation of Biotinidase Deficiency.

作者信息

Işeri-Erten Sevgin Özlem, Dikmen Zeliha Günnur, Ulusu Nuriye Nuray

机构信息

Hacettepe University, Faculty of Medicine, Department of Biochemistry, Ankara, Turkey.

Koç University, School of Medicine, Department of Biochemistry, Istanbul, Turkey.

出版信息

J Med Biochem. 2016 Apr;35(2):123-129. doi: 10.1515/jomb-2016-0004. Epub 2016 May 9.

DOI:10.1515/jomb-2016-0004
PMID:28356871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5346788/
Abstract

BACKGROUND

Biotin, a water-soluble vitamin, is used as a co-factor by enzymes involved in carboxylation reactions. Biotinidase (BTD) catalyzes the recycling of biotin from endogenous and dietary sources. Biotinidase deficiency (BD) is an autosomal recessively inherited disorder of biotin recycling that is associated with neurologic and cutaneous consequences when untreated. The aim of the study was to compare the results of spectrophotometric and fluorimetric methods, as well as to evaluate the advantages and disadvantages of both methods in current research practices.

METHODS

Study group was chosen among the BD suspected newborn, children and parents (n = 52) who applied to Hacettepe University Pediatric Metabolism Unit.

RESULTS

BTD activity is stable for 2 hours at room temperature and at 4 °C, and for 4 months at -20 °C and -80 °C. Genetic and clinical results showed that 25% of the total number of patients had complete BD which was treated with 10 mg/day biotin, while 15.38% of the patients had partial BD, and they were prescribed biotin 5 mg/day. The area under the ROC curve was 0.960±0.25 and 0.927± 0.41 for the fluorimetric and spectrophotometric method, respectively. Fluorimetric method showed 100% sensitivity and 97% specificity, whereas spectrophotometric method showed 90.5% sensitivity and 93.7% specificity.

CONCLUSIONS

Fluorimetric method is superior to the spectrophotometric method due to higher sensitivity and specificity.

摘要

背景

生物素是一种水溶性维生素,作为参与羧化反应的酶的辅助因子。生物素酶(BTD)催化生物素从内源性和饮食来源的再循环。生物素酶缺乏症(BD)是一种常染色体隐性遗传的生物素再循环障碍,未经治疗时与神经和皮肤后果相关。本研究的目的是比较分光光度法和荧光法的结果,并评估这两种方法在当前研究实践中的优缺点。

方法

研究组选自申请到哈杰泰佩大学儿科代谢科的疑似患有BD的新生儿、儿童及其父母(n = 52)。

结果

BTD活性在室温及4℃下可稳定2小时,在-20℃和-80℃下可稳定4个月。基因和临床结果显示,患者总数的25%患有完全性BD,用10mg/天的生物素治疗,而15.38%的患者患有部分性BD,他们的生物素处方剂量为5mg/天。荧光法和分光光度法的ROC曲线下面积分别为0.960±0.25和0.927±0.41。荧光法的灵敏度为100%,特异性为97%,而分光光度法的灵敏度为90.5%,特异性为93.7%。

结论

荧光法由于具有更高的灵敏度和特异性,优于分光光度法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c4/5346788/8ffab7048527/jomb-35-123-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c4/5346788/a2e78f1760cd/jomb-35-123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c4/5346788/c76b9356b811/jomb-35-123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c4/5346788/fad16a43fb19/jomb-35-123-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c4/5346788/8ffab7048527/jomb-35-123-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c4/5346788/a2e78f1760cd/jomb-35-123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c4/5346788/c76b9356b811/jomb-35-123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c4/5346788/fad16a43fb19/jomb-35-123-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c4/5346788/8ffab7048527/jomb-35-123-g004.jpg

相似文献

1
Comparison of Spectrophotometric and Fluorimetric Methods in Evaluation of Biotinidase Deficiency.分光光度法和荧光法在生物素酶缺乏症评估中的比较
J Med Biochem. 2016 Apr;35(2):123-129. doi: 10.1515/jomb-2016-0004. Epub 2016 May 9.
2
Evaluation of clinical, laboratory, and molecular genetic features of patients with biotinidase deficiency.评估生物素酶缺乏症患者的临床、实验室和分子遗传特征。
Eur J Pediatr. 2024 Mar;183(3):1341-1351. doi: 10.1007/s00431-023-05376-4. Epub 2023 Dec 23.
3
Single center experience of biotinidase deficiency: 259 patients and six novel mutations.生物素酶缺乏症的单中心经验:259例患者及6种新突变
J Pediatr Endocrinol Metab. 2018 Aug 28;31(8):917-926. doi: 10.1515/jpem-2018-0148.
4
High frequency of biotinidase deficiency in Italian population identified by newborn screening.通过新生儿筛查发现意大利人群中生物素酶缺乏症的高发病率。
Mol Genet Metab Rep. 2020 Dec 5;25:100689. doi: 10.1016/j.ymgmr.2020.100689. eCollection 2020 Dec.
5
Neonatal screening for biotidinidase deficiency: results of a 1-year pilot study in four cities in central Anatolia.新生儿生物素酶缺乏症筛查:安纳托利亚中部四个城市的1年试点研究结果。
J Pediatr Endocrinol Metab. 2009 Dec;22(12):1113-6. doi: 10.1515/jpem.2009.22.12.1113.
6
Clinical, biochemical and mutational findings in biotinidase deficiency among Malaysian population.马来西亚人群中生物素酶缺乏症的临床、生化及突变研究结果
Mol Genet Metab Rep. 2019 Dec 19;22:100548. doi: 10.1016/j.ymgmr.2019.100548. eCollection 2020 Mar.
7
Twenty-seven mutations with three novel pathologenic variants causing biotinidase deficiency: a report of 203 patients from the southeastern part of Turkey.27个突变携3种导致生物素酶缺乏症的新型致病变异:来自土耳其东南部的203例患者报告
J Pediatr Endocrinol Metab. 2018 Mar 28;31(3):339-343. doi: 10.1515/jpem-2017-0406.
8
Outcomes of oral biotin treatment in patients with biotinidase deficiency - Twenty years follow-up.生物素酶缺乏症患者口服生物素治疗的结果——20年随访
Mol Genet Metab Rep. 2015 Oct 6;5:33-35. doi: 10.1016/j.ymgmr.2015.09.004. eCollection 2015 Dec.
9
Newborn Screening for Biotinidase Deficiency. The Experience of a Regional Center in Italy.新生儿生物素酶缺乏症筛查:意大利某地区中心的经验
Front Pediatr. 2021 May 31;9:661416. doi: 10.3389/fped.2021.661416. eCollection 2021.
10
Clinical, Biochemical and Genetic Analysis of Biotinidase Deficiency in Iranian Population.伊朗人群生物素酶缺乏症的临床、生化及遗传学分析
Arch Iran Med. 2016 Nov;19(11):774-778.

引用本文的文献

1
High Incidence of Partial Biotinidase Deficiency in the First 3 Years of a Regional Newborn Screening Program in Italy.意大利地区新生儿筛查项目第 1-3 年期间部分生物素酶缺乏症的高发率。
Int J Environ Res Public Health. 2022 Jul 2;19(13):8141. doi: 10.3390/ijerph19138141.
2
Recovery of enzyme activity in biotinidase deficient individuals during early childhood.儿童早期生物素酶缺乏症个体中酶活性的恢复。
J Inherit Metab Dis. 2022 May;45(3):605-620. doi: 10.1002/jimd.12490. Epub 2022 Mar 3.
3
Two novel BTD mutations causing profound biotinidase deficiency in a Chinese patient.

本文引用的文献

1
Curious Cases of the Enzymes.酶的奇妙案例
J Med Biochem. 2015 Jul;34(3):271-281. doi: 10.2478/jomb-2014-0045. Epub 2015 Jul 14.
2
Different Viewpoints: International Perspectives on Newborn Screening.不同观点:新生儿筛查的国际视角
J Med Biochem. 2015 Jan;34(1):18-22. doi: 10.2478/jomb-2014-0040. Epub 2014 Oct 8.
3
A Turkish 3-center study evaluation of serum folic acid and vitamin B12 levels in Alzheimer disease.一项评估阿尔茨海默病患者血清叶酸和维生素 B12 水平的土耳其 3 中心研究。
两种新型 BTD 突变导致中国患者严重生物素酶缺乏症。
Mol Genet Genomic Med. 2021 Feb;9(2):e1591. doi: 10.1002/mgg3.1591. Epub 2021 Jan 16.
4
Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.生物素酶缺乏症的实验室诊断,2017 年更新:美国医学遗传学与基因组学学院的技术标准和指南。
Genet Med. 2017 Oct;19(10). doi: 10.1038/gim.2017.84. Epub 2017 Jul 5.
5
Evaluation of Renal Function in Alzheimer's Disease and Geriatric Patients: Results from a Turkish Two-center Study.阿尔茨海默病和老年患者的肾功能评估:一项土耳其双中心研究的结果
J Med Biochem. 2017 Jan 25;36(1):54-61. doi: 10.1515/jomb-2016-0028. eCollection 2017 Jan.
Turk J Med Sci. 2015;45(5):1159-66. doi: 10.3906/sag-1406-136.
4
Glucose-6-phosphate dehydrogenase deficiency and Alzheimer's disease: Partners in crime? The hypothesis.葡萄糖-6-磷酸脱氢酶缺乏症与阿尔茨海默病:共犯?该假说。
Med Hypotheses. 2015 Aug;85(2):219-23. doi: 10.1016/j.mehy.2015.05.006. Epub 2015 May 11.
5
Glucose-6-Phosphate Dehydrogenase Screening in Israel-Arab and Palestinian-Arab Neonates.以色列-阿拉伯和巴勒斯坦-阿拉伯新生儿葡萄糖-6-磷酸脱氢酶筛查。
J Pediatr. 2015 Jul;167(1):169-72. doi: 10.1016/j.jpeds.2015.04.039. Epub 2015 Jun 5.
6
The development and organization of newborn screening programs in Turkey.土耳其新生儿筛查项目的发展与组织。
J Clin Lab Anal. 2014 Jan;28(1):63-9. doi: 10.1002/jcla.21645. Epub 2013 Dec 27.
7
Novel application of digital microfluidics for the detection of biotinidase deficiency in newborns.数字微流控技术在新生儿生物素酶缺乏症检测中的新应用。
Clin Biochem. 2013 Dec;46(18):1889-91. doi: 10.1016/j.clinbiochem.2013.09.003. Epub 2013 Sep 11.
8
Establishment and development of a national newborn screening programme for congenital hypothyroidism in Turkey.土耳其先天性甲状腺功能减退症国家新生儿筛查项目的建立与发展。
J Clin Res Pediatr Endocrinol. 2013;5(2):73-9. doi: 10.4274/Jcrpe.929.
9
Newborn screening: what pediatricians should know.新生儿筛查:儿科医生应了解的内容。
J Pediatr (Rio J). 2008 Aug;84(4 Suppl):S80-90. doi: 10.2223/JPED.1790.
10
Biotinidase deficiency: clinical and MRI findings consistent with myelopathy.生物素酶缺乏症:与脊髓病一致的临床和磁共振成像表现
Pediatr Neurol. 2003 Jul;29(1):56-8. doi: 10.1016/s0887-8994(03)00042-0.